There's a new report from GBI Research on eclinical trial technologies. The report mentions Oracle Corporation, SAS, Clinplus, Phase Forward, Perceptive Informatics and Omnicomm.

CRF Health, an ediary firm, announced a new version of its system for tablet computers. Here's a release.

Kendle is looking for a senior statistical programmer in India, according to this job posting.

Sanofi-Pasteur, the vaccine division of the French pharma, is the latest firm to decide that clinical data management is a non-core activity. India-centric outsourcing firm Cognizant Technology won the account. In a recent call with investors, Cognizant president and CEO Francisco D’Souza noted that Sanofi Pasteur has selected his company as its "global partner for clinical trial data management, among other areas. Today we’re executing over 30 large clinical studies in partnership with Sanofi-Pasteur. Most notably we have helped the company meet aggressive H1N1 deadlines on five critical studies. Our partnership has enabled the company to increase effectiveness as measured by time to value and reduce process hiccups for bringing vaccines to market. Importantly our pricing model at Sanofi Pasteur is transaction and outcome based, demonstrating the evolution of our services delivery model." Here's the transcript at Seeking Alpha.

Would physicians using electronic health record (EHR) systems be more inclined to report drug safety issues? That's the finding of a Pfizer survey of 300 U.S. primary care doctors. As far as we can tell, the data have not been published in a peer-reviewed journal. The news accounts about the survey indicate that it did not measure actual physician reporting activity; rather, it asked doctors how they believed they would use EHR technology.

The FDA warned about internet scam artists posing as its inspectors. "No FDA official will ever contact a consumer by phone demanding money or any other form of payment," says Michael Chappell, acting commissioner for regulatory affairs at the agency. Here's an article and a release.

Ediary firm PHT is commenting on the final version of the FDA guidance document on patient-reported outcomes (PRO), which the federal bureaucracy had swallowed up for four years. Readers who expect the agency to showcase any deep understanding of PRO will be disappointed. Here's the text of the guidance document and a link to the same document in PDF format.

Have a news release? Send it to .(JavaScript must be enabled to view this email address)